CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in URGN — UroGen Pharma Ltd.
CIK 884546
SAN FRANCISCO, CA
Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,590,618
-$540,344 QoQ
Shares Held
88,466
-2.8% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. URGN ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in URGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,590,618 | 88,466 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,130,962 | 90,989 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,816,627 | 91,059 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,272,702 | 92,898 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,034,629 | 93,547 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $995,956 | 93,517 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,149,261 | 90,493 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,391,347 | 82,917 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $943,200 | 62,880 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $943,200 | 62,880 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $649,979 | 46,394 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $462,893 | 44,724 | Shares | Sole | 2023-08-10 | |
| 2022-03-31 | $371,821 | 42,689 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $405,972 | 42,689 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $718,028 | 42,689 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $618,664 | 40,515 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $795,816 | 40,853 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $739,468 | 41,036 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $771,021 | 39,970 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,091,711 | 41,796 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $723,661 | 40,564 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||